• International Consensus on the Use of Genetics in the Management of Hereditary Angioedema 

      Germenis A.E., Margaglione M., Pesquero J.B., Farkas H., Cichon S., Csuka D., Lera A.L., Rijavec M., Jolles S., Szilagyi A., Trascasa M.L., Veronez C.L., Drouet C., Zamanakou M., Andrejevic S., Aygören-Pürsün E., Bara N.-A., Bernstein J., Bork K., Bouillet L., Bova M., Boysen H.H., Bygum A., Caballero T., Castaldo A., Christiansen S., Cicardi M., Fabiani J., Katelaris C., Dewald G., Gökmen N.M., Gonzalez-Quevedo M.T., Gooi J., Grivcheva-Panovska V., Grumach A., Hakl R., Hardy G., Jesenak M., Kaplan A., Kirschfink M., Köhalmi K.V., Leibovich I., Longhurst H.J., Lumry W., Magerl M., Saguer I.M., Nagy I.B., Nieto S., Nordenfelt P., Porębski G., Psarros F., Reshef A., Riedl M.A., Sheikh F., Peter S., Speletas M., Staevska M., Stobiecki M., Triggiani M., Veszeli N., Waserman S., Weber C., Wuillemin W., Zuraw B. (2020)
      Hereditary angioedema (HAE) is becoming much more genetically complex than was initially considered. Thus, the role of HAE genetics is expanding beyond research laboratories, and the genotyping of subjects suffering from ...
    • SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics 

      Papaioannou A.I., Fouka E., Tzanakis N., Antoniou K., Samitas K., Zervas E., Kostikas K., Bartziokas K., Porpodis K., Papakosta D., Tzouvelekis A., Gerogianni I., Kotsiou O., Makris M., Rovina N., Vlachou G., Markatos M., Vittorakis S., Katsoulis K., Papanikolaou I., Afthinos A., Katsaounou P., Steiropoulos P., Latsios D., Dimakou K., Koukidou S., Hillas G., Tryfon S., Kallieri M., Georgopoulou A., Avarlis P., Bakakos P., Markopoulou K., Gaki E., Paspala A., Kyriakaki Z., Gourgoulianis K.I., Papiris S., Loukides S. (2022)
      Background: At the beginning of the pandemic, there have been considerable concerns regarding coronavirus disease 2019 (COVID-19) severity and outcomes in patients with severe asthma treated with biologics. Objective: To ...